Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ABOBOTULINUMTOXINA Cause Off label use? 2,271 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 2,271 reports of Off label use have been filed in association with ABOBOTULINUMTOXINA. This represents 39.2% of all adverse event reports for ABOBOTULINUMTOXINA.

2,271
Reports of Off label use with ABOBOTULINUMTOXINA
39.2%
of all ABOBOTULINUMTOXINA reports
29
Deaths
115
Hospitalizations

How Dangerous Is Off label use From ABOBOTULINUMTOXINA?

Of the 2,271 reports, 29 (1.3%) resulted in death, 115 (5.1%) required hospitalization, and 20 (0.9%) were considered life-threatening.

Is Off label use Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ABOBOTULINUMTOXINA. However, 2,271 reports have been filed with the FAERS database.

What Other Side Effects Does ABOBOTULINUMTOXINA Cause?

Drug ineffective (1,677) Product preparation error (751) Headache (379) Overdose (344) Inappropriate schedule of drug administration (318) Therapeutic response shortened (313) Eyelid ptosis (301) Injection site pain (278) Muscular weakness (272) Intentional product misuse (259)

What Other Drugs Cause Off label use?

RITUXIMAB (39,751) INFLIXIMAB (34,801) DENOSUMAB (34,612) METHOTREXATE (24,020) VEDOLIZUMAB (21,017) ETANERCEPT (20,178) TOCILIZUMAB (18,256) PREDNISONE (17,867) LENALIDOMIDE (17,017) ADALIMUMAB (16,417)

Which ABOBOTULINUMTOXINA Alternatives Have Lower Off label use Risk?

ABOBOTULINUMTOXINA vs ABRAXANE ABOBOTULINUMTOXINA vs ABROCITINIB ABOBOTULINUMTOXINA vs ACALABRUTINIB ABOBOTULINUMTOXINA vs ACAMPROSATE ABOBOTULINUMTOXINA vs ACARBOSE

Related Pages

ABOBOTULINUMTOXINA Full Profile All Off label use Reports All Drugs Causing Off label use ABOBOTULINUMTOXINA Demographics